We are live on ! Find out more
CA

Cullinan Associates Portfolio holdings

AUM $1.24B
1-Year Est. Return 28.12%
This Fund
S&P 500
This Quarter Est. Return
+3.79%
1 Year Est. Return
+28.12%
3 Year Est. Return
+86.66%
5 Year Est. Return
+111.98%
10 Year Est. Return
+372.59%
AUM
$1.28B
AUM Growth
+$57.7M
Cap. Flow
+$14.6M
Cap. Flow %
1.14%
Top 10 Hldgs %
39.8%
Holding
204
New
5
Increased
75
Reduced
74
Closed
6

Top Buys

Rank Stock Value
1
SPGI icon
S&P Global
SPGI
+$12.5M
2
AAPL icon
Apple
AAPL
+$12.3M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$9.31M
4
QCOM icon
Qualcomm
QCOM
+$5.63M
5
XOM icon
ExxonMobil
XOM
+$5.44M

Top Sells

Rank Stock Value
1
CL icon
Colgate-Palmolive
CL
+$7.59M
2
UPS icon
United Parcel Service
UPS
+$7.38M
3
MCD icon
McDonald's
MCD
+$7.32M
4
LHX icon
L3Harris
LHX
+$5.13M
5
BP icon
BP
BP
+$5.09M

Sector Composition

Rank Sector Weight
1 Consumer Staples 29.24%
2 Technology 13.14%
3 Healthcare 11.82%
4 Financials 11.62%
5 Industrials 7.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STI
26
DELISTED
SunTrust Banks, Inc.
STI
$11.3M 0.88%
199,000
-5,200
-3% -$289K
JPM icon
27
JPMorgan Chase
JPM
$930B
$11.2M 0.87%
122,654
+2,931
+2% +$253K
INTC icon
28
Intel
INTC
$490B
$11.1M 0.86%
328,245
+25,817
+9% +$924K
RTX icon
29
RTX Corp
RTX
$289B
$11M 0.86%
143,148
-1,224
-0.8% -$91.7K
ORCL icon
30
Oracle
ORCL
$337B
$11M 0.86%
219,150
+45,150
+26% +$2.06M
PFE icon
31
Pfizer
PFE
$141B
$10.4M 0.81%
327,132
+23,114
+8% +$729K
JD icon
32
JD.com
JD
$40.7B
$10.4M 0.81%
265,500
-62,000
-19% -$2.34M
DIS icon
33
Walt Disney
DIS
$165B
$10.1M 0.79%
95,481
+5,010
+6% +$549K
TFC icon
34
Truist Financial
TFC
$62.9B
$10.1M 0.79%
222,773
-5,700
-2% -$247K
CVX icon
35
Chevron
CVX
$390B
$10.1M 0.79%
96,821
+14,790
+18% +$1.57M
AFL icon
36
Aflac
AFL
$63.8B
$9.87M 0.77%
254,000
+4,000
+2% +$150K
MXIM
37
DELISTED
Maxim Integrated Products
MXIM
$9.63M 0.75%
214,501
-4,800
-2% -$220K
SPY icon
38
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$9.58M 0.75%
39,636
-584
-1% -$140K
TXN icon
39
Texas Instruments
TXN
$256B
$9.52M 0.74%
123,800
+1,575
+1% +$126K
MDT icon
40
Medtronic
MDT
$107B
$9.41M 0.73%
106,052
-121
-0.1% -$10.2K
CVS icon
41
CVS Health
CVS
$138B
$9.27M 0.72%
115,170
+10,060
+10% +$794K
MON
42
DELISTED
Monsanto Co
MON
$8.89M 0.69%
75,140
-930
-1% -$109K
WFC icon
43
Wells Fargo
WFC
$261B
$8.7M 0.68%
157,064
-6,842
-4% -$367K
CELG
44
DELISTED
Celgene Corp
CELG
$8.35M 0.65%
64,318
+2,000
+3% +$245K
HAS icon
45
Hasbro
HAS
$12.5B
$8.1M 0.63%
72,630
+16,030
+28% +$1.65M
PM icon
46
Philip Morris
PM
$304B
$7.91M 0.62%
67,306
-3,500
-5% -$405K
BMY icon
47
Bristol-Myers Squibb
BMY
$128B
$7.37M 0.57%
132,246
-2,250
-2% -$122K
CL icon
48
Colgate-Palmolive
CL
$72.5B
$7.21M 0.56%
97,290
-102,167
-51% -$7.59M
COF icon
49
Capital One
COF
$123B
$7.02M 0.55%
84,995
VZ icon
50
Verizon
VZ
$188B
$6.94M 0.54%
155,315
-7,330
-5% -$341K

Similar funds

Cullinan Associates's Q2 2017 Portfolio in Review

As of Q2 2017, Cullinan Associates held 204 positions worth $1.28B, up 4.7% from $1.23B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Cullinan Associates's Q2 2017 filing shows 5 new, 75 increased, 74 reduced and 6 closed positions. Its largest new stake was S&P Global: 90,000 shares worth $13.1M. The largest sale was Colgate-Palmolive, an estimated $7.59M.

By sector, the portfolio is most concentrated in Consumer Staples at 29% of assets, down from 31% a quarter earlier, followed by Technology and Healthcare.

  • Cullinan Associates's largest Q2 2017 buy was S&P Global: 90,000 shares worth $13.1M.
  • Cullinan Associates added most to Apple in Q2 2017, an estimated $12.3M increase.
  • Cullinan Associates's biggest Q2 2017 reduction was Colgate-Palmolive, cutting an estimated $7.59M.
  • Cullinan Associates fully exited Target in Q2 2017, selling an estimated $2.57M.
  • Cullinan Associates's ten largest holdings make up 40% of its $1.28B portfolio in Q2 2017.
  • Cullinan Associates opened 5 new positions and closed 6 in Q2 2017.
  • Cullinan Associates's portfolio value rose 4.7% quarter-over-quarter to $1.28B.

Based on Cullinan Associates's 13F filing for Q2 2017, filed 12 Jul 2017.